AZ Lynparza Head Hopes 2020 Will See PARP Inhibitor Treating Pancreatic Cancer

Pancreas
Lynparza Phase III POLO Trial Met Primary PFS Endpoint In Pancreatic Cancer • Source: Shutterstock

More from Clinical Trials

More from R&D